EndoSonics has received FDA 510(k) clearance for a third-generation intravascular ultrasound catheter the company calls the “Avanar.” The Avanar has upgraded integrated circuit technology to improve image quality for arterial sizing and
EndoSonics has received FDA 510(k) clearance for a third-generation intravascular ultrasound catheter the company calls the Avanar. The Avanar has upgraded integrated circuit technology to improve image quality for arterial sizing and definitive morphologic assessment, according to the firm. The device is part of EndoSonics digital intravascular ultrasound product line.
The Avanar has a smaller profile to allow easier and more rapid access through stents; tight lesions; and small, tortuous arteries. Reinhard J. Warnking, CEO and president of EndoSonics, said 80% of his companys revenue comes from sales of disposable products such as the Avanar. EndoSonics is a Rancho Cordova, CA-based developer, manufacturer, and marketer of intravascular ultrasound imaging products.
